HNGE
Hinge Health, Inc.Company with tickers: HNGE
CIK
1673743
CUSIP
433313103
Shares Outstanding
54,655,926
13F Activity (30d)
180 filings
180 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $182,307,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | $28,074,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Gross Profit | $154,233,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Expenses | $122,164,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $30,338,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $32,069,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $35,128,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $0.43 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $0.41 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |